Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

The first introduced malaria case reported from Sri Lanka after elimination: implications for preventing the re-introduction of malaria in recently eliminated countries.

Karunasena VM, Marasinghe M, Koo C, Amarasinghe S, Senaratne AS, Hasantha R, Hewavitharana M, Hapuarachchi HC, Herath HDB, Wickremasinghe R, Mendis KN, Fernando D, Ranaweera D.

Malar J. 2019 Jun 24;18(1):210. doi: 10.1186/s12936-019-2843-6.

2.

Global Epidemiology of Plasmodium vivax.

Howes RE, Battle KE, Mendis KN, Smith DL, Cibulskis RE, Baird JK, Hay SI.

Am J Trop Med Hyg. 2016 Dec 28;95(6 Suppl):15-34. doi: 10.4269/ajtmh.16-0141. Epub 2016 Jul 11. Review.

3.

Malaria elimination in Sri Lanka: what it would take to reach the goal.

Premaratne R, Ortega L, Janakan N, Mendis KN.

WHO South East Asia J Public Health. 2014 Jan-Mar;3(1):85-89. doi: 10.4103/2224-3151.206892.

4.

Association of high plasma TNF-alpha levels and TNF-alpha/IL-10 ratios with TNF2 allele in severe P. falciparum malaria patients in Sri Lanka.

Perera MK, Herath NP, Pathirana SL, Phone-Kyaw M, Alles HK, Mendis KN, Premawansa S, Handunnetti SM.

Pathog Glob Health. 2013 Jan;107(1):21-9. doi: 10.1179/2047773212Y.0000000069.

5.

An indigenous case of Plasmodium ovale infection in Sri Lanka.

Wickremasinghe R, Galapaththy GN, Fernando WA, de Monbrison F, Wijesinghe RS, Mendis KN, Picot S, Ringwald P, Wickremasinghe AR.

Am J Trop Med Hyg. 2008 Feb;78(2):206-7.

PMID:
18256413
6.

A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies.

Bosman A, Mendis KN.

Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):193-7. Review.

PMID:
18165492
7.

Malaria mortality rates in South Asia and in Africa: implications for malaria control.

Alles HK, Mendis KN, Carter R.

Parasitol Today. 1998 Sep;14(9):369-75.

PMID:
17040819
8.

A randomized, double-blind, placebo-controlled, clinical trial of the impact of malaria prevention on the educational attainment of school children.

Fernando D, de Silva D, Carter R, Mendis KN, Wickremasinghe R.

Am J Trop Med Hyg. 2006 Mar;74(3):386-93.

PMID:
16525095
9.

ABO-blood-group types and protection against severe, Plasmodium falciparum malaria.

Pathirana SL, Alles HK, Bandara S, Phone-Kyaw M, Perera MK, Wickremasinghe AR, Mendis KN, Handunnetti SM.

Ann Trop Med Parasitol. 2005 Mar;99(2):119-24.

PMID:
15814030
10.

The impact of repeated malaria attacks on the school performance of children.

Fernando SD, Gunawardena DM, Bandara MR, De Silva D, Carter R, Mendis KN, Wickremasinghe AR.

Am J Trop Med Hyg. 2003 Dec;69(6):582-8.

PMID:
14740872
11.

Cognitive performance at school entry of children living in malaria-endemic areas of Sri Lanka.

Fernando D, Wickremasinghe R, Mendis KN, Wickremasinghe AR.

Trans R Soc Trop Med Hyg. 2003 Mar-Apr;97(2):161-5.

PMID:
14584369
12.

The paroxysm of Plasmodium vivax malaria.

Karunaweera ND, Wijesekera SK, Wanasekera D, Mendis KN, Carter R.

Trends Parasitol. 2003 Apr;19(4):188-93. Review.

PMID:
12689650
13.

Evolutionary and historical aspects of the burden of malaria.

Carter R, Mendis KN.

Clin Microbiol Rev. 2002 Oct;15(4):564-94. Review. Erratum in: Clin Microbiol Rev. 2003 Jan;16(1):173..

14.

Spatial targeting of interventions against malaria.

Carter R, Mendis KN, Roberts D.

Bull World Health Organ. 2000;78(12):1401-11. Epub 2003 Nov 17.

15.

Quantifying genetic and nongenetic contributions to malarial infection in a Sri Lankan population.

Mackinnon MJ, Gunawardena DM, Rajakaruna J, Weerasingha S, Mendis KN, Carter R.

Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12661-6.

16.

Malaria transmission-blocking vaccines--how can their development be supported?

Carter R, Mendis KN, Miller LH, Molineaux L, Saul A.

Nat Med. 2000 Mar;6(3):241-4. Review. No abstract available.

PMID:
10700212
17.

TNFalpha*2 marks high risk of severe disease during Plasmodium falciparum malaria and other infections in Sri Lankans.

Wattavidanage J, Carter R, Perera KL, Munasingha A, Bandara S, McGuinness D, Wickramasinghe AR, Alles HK, Mendis KN, Premawansa S.

Clin Exp Immunol. 1999 Feb;115(2):350-5.

18.

Malaria risk factors in an endemic region of Sri Lanka, and the impact and cost implications of risk factor-based interventions.

Gunawardena DM, Wickremasinghe AR, Muthuwatta L, Weerasingha S, Rajakaruna J, Senanayaka T, Kotta PK, Attanayake N, Carter R, Mendis KN.

Am J Trop Med Hyg. 1998 May;58(5):533-42.

PMID:
9598437
19.

Demonstration of anti-disease immunity to Plasmodium vivax malaria in Sri Lanka using a quantitative method to assess clinical disease.

Karunaweera ND, Carter R, Grau GE, Mendis KN.

Am J Trop Med Hyg. 1998 Feb;58(2):204-10.

PMID:
9502605
20.

Optimizing the malaria data recording system through a study of case detection and treatment in Sri Lanka.

Abeysekera T, Wickremasinghe AR, Gunawardena DM, Mendis KN.

Trop Med Int Health. 1997 Nov;2(11):1057-67.

21.
22.

The ParaSight-F dipstick test as a routine diagnostic tool for malaria in Sri Lanka.

Kodisinghe HM, Perera KL, Premawansa S, Naotunne T, Wickramasinghe AR, Mendis KN.

Trans R Soc Trop Med Hyg. 1997 Jul-Aug;91(4):398-402.

PMID:
9373632
23.

Cloning and characterisation of a gene from Plasmodium vivax and P. knowlesi: homology with valine-tRNA synthetase.

Snewin VA, Khouri E, Mattei D, Tekaia F, Delarue M, Mendis KN, David PH.

Gene. 1996 Sep 16;173(2):137-45.

PMID:
8964490
24.

Features of recrudescent chloroquine-resistant Plasmodium falciparum infections confer a survival advantage on parasites and have implications for disease control.

Handunnetti SM, Gunewardena DM, Pathirana PP, Ekanayake K, Weerasinghe S, Mendis KN.

Trans R Soc Trop Med Hyg. 1996 Sep-Oct;90(5):563-7.

PMID:
8944275
25.

A malaria parasite toxin associated with Plasmodium vivax paroxysms.

Wijesekera SK, Carter R, Rathnayaka L, Mendis KN.

Clin Exp Immunol. 1996 May;104(2):221-7.

26.

Clinical disease and pathogenesis in malaria.

Mendis KN, Carter R.

Parasitol Today. 1995 May;11(5):PTI1-16.

PMID:
15275352
27.

A new polymorphic marker for PCR typing of Plasmodium vivax parasites.

Snewin VA, Khouri E, Wattavidanage J, Perera L, Premawansa S, Mendis KN, David PH.

Mol Biochem Parasitol. 1995 Apr;71(1):135-8. No abstract available.

PMID:
7630377
28.

Atypical presentations of malaria associated with chloroquine resistance.

Alles HK, De Silva D, Mendis KN.

Ceylon Med J. 1995 Mar;40(1):45. No abstract available.

PMID:
7781097
29.

Transmission blocking immunity in Plasmodium vivax malaria: antibodies raised against a peptide block parasite development in the mosquito vector.

Snewin VA, Premawansa S, Kapilananda GM, Ratnayaka L, Udagama PV, Mattei DM, Khouri E, Del Giudice G, Peiris JS, Mendis KN, David PH.

J Exp Med. 1995 Jan 1;181(1):357-62.

30.

Plasmodium vivax merozoite surface protein 1 C-terminal recombinant proteins in baculovirus.

Longacre S, Mendis KN, David PH.

Mol Biochem Parasitol. 1994 Apr;64(2):191-205.

PMID:
7935598
31.

Sulphadoxine-pyrimethamine and chloroquine resistant Plasmodium falciparum infection in Sri Lanka.

Handunnetti SM, Jayasinghe S, Pathirana PP, Fernando R, Sheriff MH, Mendis KN.

Ceylon Med J. 1994 Mar;39(1):45-6. No abstract available.

PMID:
8194148
32.

Transient increase in circulating gamma/delta T cells during Plasmodium vivax malarial paroxysms.

Perera MK, Carter R, Goonewardene R, Mendis KN.

J Exp Med. 1994 Jan 1;179(1):311-5.

33.

Patterns of acquired anti-malarial immunity in Sri Lanka.

Gunewardena DM, Carter R, Mendis KN.

Mem Inst Oswaldo Cruz. 1994;89 Suppl 2:63-5. No abstract available.

35.

Plasmodium vivax:recombination between potential allelic types of the merozoite surface protein MSP1 in parasites isolated from patients.

Premawansa S, Snewin VA, Khouri E, Mendis KN, David PH.

Exp Parasitol. 1993 Mar;76(2):192-9.

PMID:
8454028
36.

Infectivity of Plasmodium vivax and P. falciparum to Anopheles tessellatus; relationship between oocyst and sporozoite development.

Gamage-Mendis AC, Rajakaruna J, Weerasinghe S, Mendis C, Carter R, Mendis KN.

Trans R Soc Trop Med Hyg. 1993 Jan-Feb;87(1):3-6.

PMID:
8465388
37.

Transmission blocking immunity to human Plasmodium vivax malaria in an endemic population in Kataragama, Sri Lanka.

Gamage-Mendis AC, Rajakaruna J, Carter R, Mendis KN.

Parasite Immunol. 1992 Jul;14(4):385-96.

PMID:
1437231
38.

Tumour necrosis factor-dependent parasite-killing effects during paroxysms in non-immune Plasmodium vivax malaria patients.

Karunaweera ND, Carter R, Grau GE, Kwiatkowski D, Del Giudice G, Mendis KN.

Clin Exp Immunol. 1992 Jun;88(3):499-505.

39.

Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria.

Karunaweera ND, Grau GE, Gamage P, Carter R, Mendis KN.

Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3200-3.

40.

Serological relationship of tumor necrosis factor-inducing exoantigens of Plasmodium falciparum and Plasmodium vivax.

Bate CA, Taverne J, Karunaweera ND, Mendis KN, Kwiatkowski D, Playfair JH.

Infect Immun. 1992 Mar;60(3):1241-3.

41.

Method to estimate relative transmission efficiencies of Anopheles species (Diptera: Culicidae) in human malaria transmission.

Mendis C, Herath PR, Rajakaruna J, Weerasinghe S, Gamage-Mendis AC, Mendis KN, De Zoysa AP.

J Med Entomol. 1992 Mar;29(2):188-96.

PMID:
1495028
42.

Anti-circumsporozoite protein antibodies measure age related exposure to malaria in Kataragama, Sri Lanka.

Mendis C, Del Giudice G, Gamage-Mendis AC, Tougne C, Pessi A, Weerasinghe S, Carter R, Mendis KN.

Parasite Immunol. 1992 Jan;14(1):75-86.

PMID:
1557232
43.

The role of cytokines in Plasmodium vivax malaria.

Mendis KN, Carter R.

Mem Inst Oswaldo Cruz. 1992;87 Suppl 3:51-5. Review.

44.

Infectious reservoir of Plasmodium vivax and Plasmodium falciparum malaria in an endemic region of Sri Lanka.

Gamage-Mendis AC, Rajakaruna J, Carter R, Mendis KN.

Am J Trop Med Hyg. 1991 Oct;45(4):479-87.

PMID:
1951856
45.

Transmission blocking immunity may provide clues that antimalarial immunity is largely T-independent.

Mendis KN, Carter R.

Res Immunol. 1991 Oct;142(8):687-90. Review. No abstract available.

PMID:
1687798
46.

Clustering of malaria infections within an endemic population: risk of malaria associated with the type of housing construction.

Gamage-Mendis AC, Carter R, Mendis C, De Zoysa AP, Herath PR, Mendis KN.

Am J Trop Med Hyg. 1991 Jul;45(1):77-85.

PMID:
1867350
47.
48.

Antigenic polymorphism in malaria: is it an important mechanism for immune evasion?

Mendis KN, David PH, Carter R.

Immunol Today. 1991 Mar;12(3):A34-7. Review.

PMID:
2069676
49.

Cytokines kill malaria parasites during infection crisis: extracellular complementary factors are essential.

Naotunne TS, Karunaweera ND, Del Giudice G, Kularatne MU, Grau GE, Carter R, Mendis KN.

J Exp Med. 1991 Mar 1;173(3):523-9.

50.

A mathematical model for Plasmodium vivax malaria transmission: estimation of the impact of transmission-blocking immunity in an endemic area.

De Zoysa AP, Mendis C, Gamage-Mendis AC, Weerasinghe S, Herath PR, Mendis KN.

Bull World Health Organ. 1991;69(6):725-34.

Supplemental Content

Loading ...
Support Center